Recruiting
Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease
NCT05388149
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- University Health Network: Princess Margaret Cancer Centre Toronto, Ontario, Canada